News

European Society of Cardiology recommends (rivaroxaban) XARELTO® 2.5 mg plus acetylsalicylic acid for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromes

Bayer completes sale of iconic Coppertone™ brand to Beiersdorf

Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion

Yellow Wood Partners to acquire iconic Dr. Scholl’s™ brand from Bayer

Beiersdorf to acquire iconic Coppertone™ brand from Bayer

Delaro fungicide now registered for cereals

Bayer Fund to provide nearly $100,000 in scholarships to eligible Canadian high school students in 2019